Clinical trial
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Phase III, Randomized, Sham-controlled Clinical Trial
NCT04651907 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Phase III, Randomized, Sham-controlled Clinical Trial
- Lead sponsor
- China Medical University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 18, 2021
- Completion date
- June 30, 2025
- Enrollment
- 69 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy (cipn)